Stage IVA Lung Cancer
1 clinical trials · Condition
| Record | Firm | Date |
|---|---|---|
| Brigatinib and Binimetinib in Treating Patients With Stage IIIB-IV ALK or ROS1-Rearranged Non-small Cell Lung Cancer (NCT04005144) | University of California, San Francisco | 2020-02-25 |
Track Stage IVA Lung Cancer automatically
Every clearance here is in the API, with alerts when new ones post.